Technology Opportunities

Refine / Revise Search2 technologies found
page 1 of 1
Circulating microRNAs as Biomarkers for B-Cell Depletion Therapy/ Rituximab in Neuromyelitis Optica (Hadasit)
Need:Neuromyelitis optica (NMO) is a chronic autoimmune disease of the central nervous system (CNS). The main immunological feature of the disease is the presence of autoantibodies to Aquaporin 4 (AQP4+), identified in about 82% of cases. Currently, there are no reliable biomarkers for ...
Scientific Contact: Adi Vaknin
More Details...
Decoy Oligonucleotides Corresponding to NF-KappaB Binding Site in MGMT Promoter for Cancer Treatment and Drug Resistance. (Hadasit)
Need: There is a substantial unmet need for novel anti-drug-resistant cancer treatment. Alkylating agents (A certain type of chemotherapy) are the most widely used anti-cancer drugs. Drug resistance is a common obstacle for their use in cancer patients. Specifically, patients diagnosed with ...
Scientific Contact: Iris Lavon
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.